Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease.
Warren Olanow C, Kieburtz K, Rascol O, Poewe W, Schapira AH, Emre M, Nissinen H, Leinonen M, Stocchi F; Stalevo Reduction in Dyskinesia Evaluation in Parkinson's Disease (STRIDE-PD) Investigators. Warren Olanow C, et al. Among authors: emre m. Mov Disord. 2013 Jul;28(8):1064-71. doi: 10.1002/mds.25364. Epub 2013 Apr 29. Mov Disord. 2013. PMID: 23630119 Clinical Trial.
Rivastigmine for dementia associated with Parkinson's disease.
Emre M, Aarsland D, Albanese A, Byrne EJ, Deuschl G, De Deyn PP, Durif F, Kulisevsky J, van Laar T, Lees A, Poewe W, Robillard A, Rosa MM, Wolters E, Quarg P, Tekin S, Lane R. Emre M, et al. N Engl J Med. 2004 Dec 9;351(24):2509-18. doi: 10.1056/NEJMoa041470. N Engl J Med. 2004. PMID: 15590953 Free article. Clinical Trial.
Clinical diagnostic criteria for dementia associated with Parkinson's disease.
Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B. Emre M, et al. Mov Disord. 2007 Sep 15;22(12):1689-707; quiz 1837. doi: 10.1002/mds.21507. Mov Disord. 2007. PMID: 17542011 Review.
Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force.
Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, McKeith IG, Olanow CW, Poewe W, Sampaio C, Tolosa E, Emre M. Dubois B, et al. Among authors: emre m. Mov Disord. 2007 Dec;22(16):2314-24. doi: 10.1002/mds.21844. Mov Disord. 2007. PMID: 18098298 Review.
Psychotic and compulsive symptoms in Parkinson's disease.
Verbaan D, van Rooden SM, Visser M, Marinus J, Emre M, van Hilten JJ. Verbaan D, et al. Among authors: emre m. Mov Disord. 2009 Apr 15;24(5):738-44. doi: 10.1002/mds.22453. Mov Disord. 2009. PMID: 19133665
Safety and efficacy of perampanel in advanced Parkinson's disease: a randomized, placebo-controlled study.
Eggert K, Squillacote D, Barone P, Dodel R, Katzenschlager R, Emre M, Lees AJ, Rascol O, Poewe W, Tolosa E, Trenkwalder C, Onofrj M, Stocchi F, Nappi G, Kostic V, Potic J, Ruzicka E, Oertel W; German Competence Network on Parkinson's Disease. Eggert K, et al. Among authors: emre m. Mov Disord. 2010 May 15;25(7):896-905. doi: 10.1002/mds.22974. Mov Disord. 2010. PMID: 20461807 Clinical Trial.
209 results